Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy

NAEnrolling by invitationINTERVENTIONAL

Enrollment

174

Participants

Timeline

Start Date

July 5, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Recurrent Pancreatic Ductal Adenocarcinoma

Interventions

RADIATION

Additional stereotactic body radiation therapy

5 fractions of 8 Gray stereotactic body radiation therapy in addition to standard of care.

Trial Locations (3)

Amsterdam University Medical Center, VUmc, Amsterdam

Erasmus University Medical Center, Rotterdam

University Medical Center Utrecht, Utrecht

All Listed Sponsors

collaborator

Dutch Pancreatic Cancer Group (DPCG)

UNKNOWN

lead

UMC Utrecht

OTHER